Flexion Therapeutics Announces Changes To Board Of Directors

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

BURLINGTON, Mass., June 12, 2014 (GLOBE NEWSWIRE) -- Flexion Therapeutics, Inc. (Nasdaq:FLXN) announced today recent changes to its Board of Directors. Ann Merrifield, President and CEO of PathoGenetix, Inc., has been appointed to the Board, effective June 11, 2014. In addition, Flexion Board of Directors members Bradley Bolzon, Ph.D., Versant Ventures, and Elaine Jones, Ph.D., Pfizer Venture Investments, are stepping down from the Board effective immediately.

Help employers find you! Check out all the jobs and post your resume.

Back to news